ARCHIVES

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

This article is from The Cancer Letter archive.

Vol. 06 No. 37 | September 19, 1980

Download PDF Visit The Full Archive

Related Articles

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Preliminary estimates based on NLST results: Year Of Life Saved Could Cost $38,000

July 1, 2011

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

The Pink Machine Sputters, Goes in Reverse: Komen Funding Decision Sparks Outrage

February 3, 2012

Group Chairs: Research In “Crisis” ASCO Says NCTN Budgets Cut By 40 Percent, Warns of “Dangerous Disruption of Cancer Care”

April 4, 2014